跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Airmaxx - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Airmaxx
Approved
STANDARD
Airmaxx
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
60c48fcce88c25b8
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
60c48fcce88c25b8
Drug Approval Philippines Name
Airmaxx
Product Name
Airmaxx
Registration Number
DRP-8221
Brand Name
Airmaxx
Generic Name
Montelukast (as Sodium)
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Lloyd Laboratories, Inc.
Importer
Euro-Healthcare Exponents, Inc.
Distributor
TGP Pharma, Inc.
Issuance Date
27 July 2024
Expiry Date
19 August 2029
Pharmacologic Category
Leukotriene Receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
60c48fcce88c25b8
Type
Standard
Back to Philippines FDA Approvals